Where does Sorrento Therapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sorrento Therapeutics, Inc. ranks #3,383 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sorrento Therapeutics, Inc. hold?

Sorrento Therapeutics, Inc. holds 110 US utility patents granted between 2015 and 2024, spanning 19 technology areas.

What is Sorrento Therapeutics, Inc.'s Innovation Score?

Sorrento Therapeutics, Inc. has an Innovation Score of 43.9 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Sorrento Therapeutics, Inc. focus on?

Sorrento Therapeutics, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 68 patents, ranking #251 of 6,058 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

Is Sorrento Therapeutics, Inc.'s patent grant rate increasing or decreasing?

Sorrento Therapeutics, Inc.'s recent grant velocity is +39% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Sorrento Therapeutics, Inc.'s patents?

Sorrento Therapeutics, Inc.'s patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sorrento Therapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Sorrento Therapeutics, Inc.

USPTO PatentsView assignee record - 110 granted patents across 19 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sorrento ranks #3,383 of 49,997 tracked US assignees by granted-patent volume, with 110 patents across 19 technology areas.

#3,383
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.9/100): 16.4
avg claims per patent: +39%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3383 · US Corporation #3,383 · 110 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MID 110 grants
TOP-DECILE #3,383/49,997
PHOTO-FINISH OJI Holdings
CPC-FOCUS A61P · 19 areas
INNOV-PAR 43.9/100
CLAIMS-RICH 16.4 claims/avg
TYPE-USCORP US Corporation
VEL-UP +39% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: OJI Holdings Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sorrento’s 43.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.3 pts (37%) Velocity 2.3 pts (5%) Breadth 15.4 pts (35%) Claim depth 9.9 pts (23%)

Qualcomm Incorporated · highest

85
Coulter Ventures · near

44
PME IP PTY · near

44
Qingdao Haier Joint… · near

44
Rehabilitation… · near

44
Sorrento Therapeutics · this assignee

44
3D Lighting… · lowest

7

What this shows Sorrento's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Sorrento?

Each dot is one of Sorrento’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sorrento’s own 16.4 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Sorrento vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sorrento's grants concentrate

Sorrento Therapeutics, Inc. is a focused PatentsView assignee: 19 CPC subclasses with 61.8% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (24 grants) versus a trough of 2 in 2015. By volume, Sorrento sits between OJI Holdings Corporation and 8 Rivers Capital, LLC.

Sorrento's three-year grant acceleration

From 2019–2021 to 2022–2024, Sorrento Therapeutics, Inc. moved from 63 to 22 grants (0.35x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,942. See the growth leaderboard.

OJI Holdings

110
Op-hygiene IP

110
Safran Ceramics

110
Shanghai Micro Eq…

110
The ADT Security

110
The Western Union

110
West Pharmaceutic…

110
Sorrento Therapeu… ◀

110
8 Rivers Capital

109

What this shows Sorrento holds 110 patents at rank #3,383, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sorrento

By rank, the assignees closest to #3,383 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Sorrento's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sorrento, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Sorrento ranks #251 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Qingdao Haier Joint Stock Co., Ltd. 44 PME IP PTY Ltd 44 Coulter Ventures, LLC. 44 Rehabilitation Institute of Chicago 44

Similar claim depth

Nearest assignees by average claims per patent (16.4 here).

Erico International Corporation 16.4 avg Xiamen Sanan Optoelectronics Technology Co., Ltd. 16.4 avg ETH Zurich 16.4 avg Tile, Inc. 16.4 avg

Sorrento's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sorrento Therapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	1.8%
2016	2	1.8%
2017	4	3.6%
2018	17	15.5%
2019	21	19.1%
2020	18	16.4%
2021	24	21.8%
2022	8	7.3%
2023	9	8.2%
2024	5	4.5%

Which technologies does Sorrento Therapeutics, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 68

C07K - Peptides 68

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 57

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 37

Y10T - Technical Subjects Covered BY Former US Classification 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 4

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 4

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 4

A61B - DIAGNOSIS; SURGERY; Identification 4

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 4

B01D - Separation 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sorrento Therapeutics, Inc.'s patent record in context - here's where to go next.

Sorrento Therapeutics, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 61.8% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #3,383 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sorrento Therapeutics, Inc. against OJI Holdings Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.